Purpose: To audit our experience with ultrasound-guided thrombin injection for the treatment of iatrogenic femoral artery pseudoaneurysms.

Methods: A retrospective study of 85 consecutive patients undergoing percutaneous ultrasound-guided thrombin injection of post-catheterization femoral pseudoaneurysms during the period January 2002 to May 2007.

Results: Pseudoaneurysms had a mean maximum diameter of 3.3 cm (range 1.0-7.6 cm) and a mean neck width of 3.4mm (range 1.0-7.0mm). No statistically significant correlation existed between maximum diameter and neck width (Kendall's rank correlation tau b=-0.09, p=0.5). The median dose of thrombin injected was 425 U (range 100-1500 U). The procedure resulted in complete sac thrombosis in 81 (95%) patients. Seventy-nine pseudoaneurysms thrombosed immediately after one injection, whereas two required a second thrombin injection. There were no procedural complications. The maximum diameter of the pseudoaneurysm was predictive of procedural success (Wilcoxon's rank sum test, p=0.001) and of the 5 patients with a pseudoaneurysm measuring ≥6 cm, ultrasound-guided thrombin injection was unsuccessful in 4 (4/5 versus 0/80, p<0.0001, Fisher's exact test). Three of these necessitated implantation of a stent-graft, whereas one required repeated thrombin injection and coil placement. In contrast, the pseudoaneurysm neck width did not seem to relate to the success of the procedure.

Conclusion: Percutaneous ultrasound-guided thrombin injection of is a quick, effective and safe treatment for iatrogenic femoral pseudoaneurysms. For larger pseudoaneurysms, although it is worth attempting more than one thrombin injection, endovascular repair may eventually be required.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejrad.2009.06.032DOI Listing

Publication Analysis

Top Keywords

thrombin injection
20
ultrasound-guided thrombin
16
maximum diameter
12
percutaneous ultrasound-guided
8
injection treatment
8
treatment iatrogenic
8
iatrogenic femoral
8
femoral artery
8
neck width
8
thrombin
6

Similar Publications

Objective: To investigate the safety and effectiveness of balloon occlusion and intra-sac thrombin injection in the endovascular repair of ruptured abdominal aortic aneurysm.

Methods: From October 2019 to October 2022, the clinical data of 16 patients with rAAA treated with balloon occlusion technique and intra-sac thrombin injection combined with EVAR were retrospectively analyzed, including 13 males and 3 females, aged 42-85 years, with a median age of 70.5 years.

View Article and Find Full Text PDF

Pseudoaneurysms develop as a result of disruption of the arterial wall due to trauma or iatrogenic reasons such as catheterization, and it is important due to the high risk of bleeding and rupture. Until recently, the main treatment of pseudoaneurysms was surgical repair. However, in recent years, minimally invasive methods such as ultrasound-guided compression and percutaneous thrombin injection have been used more frequently.

View Article and Find Full Text PDF

Bidirectional Enzyme Inhibition and Activation for In Situ Formation of Injectable Hydrogel Using a Bispecific Aptamer.

Langmuir

December 2024

Department of Biomedical Engineering, The Pennsylvania State University, University Park, Pennsylvania 16802, United States.

Article Synopsis
  • - The study focuses on in situ injectable hydrogels, which are important for applications in regenerative medicine and drug delivery, but face challenges in controlling gelation speed for easier injection.
  • - Researchers investigated a system using bispecific aptamers that can inhibit thrombin (an enzyme involved in clotting) to slow down the formation of fibrin hydrogels.
  • - The study found that when these aptamers interacted with complementary sequences, they could reverse the inhibition, speeding up the hydrogel formation process, demonstrating a new dynamic control for enzyme-mediated hydrogel development.
View Article and Find Full Text PDF
Article Synopsis
  • Isorhynchophylline, a Chinese herbal medicine, shows anti-inflammatory and neuroprotective effects, but its impact on platelet function was previously unknown.
  • The study found that isorhynchophylline reduces platelet aggregation and activation in a dose-dependent manner and does not affect surface levels of key receptors.
  • In vivo tests on mice indicated that isorhynchophylline impairs hemostatic function and thrombus formation, suggesting it might be useful for treating thrombotic and cardiovascular diseases.
View Article and Find Full Text PDF
Article Synopsis
  • * Symptoms and characteristics of PSAs can vary, making diagnosis important, which can be done using ultrasonography, CT scans, or other imaging techniques.
  • * Treatment options for PSAs include surgical methods, ultrasound-guided therapies, and advanced endovascular techniques, along with a discussion of risk factors and potential complications.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!